1 Akinobu Tawada,tatsuo kanda,Osamu Yokosuka.Current and future directions for treating hepatitis B virus infection.World J Hepatol, 2015,7:1541.
2 Liaw YF, Chu CM. Hepatitis B virus infection. Lancet,2009,373: 582-592.
3 中华医学会肝病学分会.中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版). 肝脏,2011,16:2-16.
4 Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet,2014,384:2053-2063.
5 Zoulim F, Locarnini S. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology,2009,137:1593-608.e1-2.
6 Fasano M, Lampertico P, Marzano A, et al. HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5years.J Hepatol, 2012, 56:1254-1258.
7 Tai DI, Tsay PK, Chen WT, et al. Relative roles of HBsAg seroclearance and mortality in the decline of HBsAg prevalence with increasing age. Am J Gastroenterol, 2010,105:1102-1109.
8 Simonetti J, Bulkow L, McMahon BJ, et al. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus. Hepatology,2010,51: 1531-1537.
9 Tseng TC, Liu CJ, Su TH, et al. Serum Hepatitis B Surface Antigen Levels Predict Surface Antigen Loss in Hepatitis B e Antigen Seroconverters. Gastroenterology, 2011,141: 517-525.
10 Tseng TC, Liu CJ, Yang HC, et al. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load. Hepatology,2012,55: 68-76.
11 Chu CM, Liaw YF.Hepatitis B surface antigen seroclearance during chronic HBV infection. Antivir Ther ,2010,15: 133-143.
12 Liu J, Yang HI, Lee MH, et al. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study. Gastroenterology,2010,139: 474-482.
13 Tseng TC, Liu CJ, Yang HC, et al. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load. Hepatology,2012,55: 68-76.
14 Cheng HR,Liu CJ,Tseng TC,et al.Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients. PloS One,2013,8:e53008.
15 Chen YC, Sheen IS, Chu CM, et al. Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B with or without concurrent infection. Gastroenterology, 2002,123:1084-1089.
16 Arase Y, Ikeda K,Suzuki F, et al. Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B. Am J Med,2006,119:71.e9-16.
17 Huo TI, Wu JC, Lee PC, et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology,1998,28:231-236. |
